Clinical trials: CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
- Condition CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies
- Funder type Industry (pharma, biotech, devices)
- Accepts healthy volunteers yes
No studies match all of these filters
Remove a filter, check the spelling of a condition or drug, or try a broader term: “lung cancer” rather than a subtype.